JHJiawei Han

Jiawei Han

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jiawei Han has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • Jue Wang

    School of Pharmacy & School of Biological and Food Engineering, Changzhou University, Changzhou, 213164, P. R. China

    8 shared publications
  • Zhimin Yue

    School of Pharmacy & School of Biological and Food Engineering, Changzhou University, Changzhou, 213164, P. R. China

    8 shared publications
  • Baimin Niu

    School of Pharmacy & School of Biological and Food Engineering, Changzhou University, Changzhou, 213164, P. R. China

    7 shared publications
  • Huizhen Sun

    School of Pharmacy & School of Biological and Food Engineering, Changzhou University, Changzhou, 213164, P. R. China

    7 shared publications
  • Jiaxin Chen

    6 shared publications
  • Wuheng Yue

    Taicang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, 215400, P. R. China

    6 shared publications

Latest Publications

  • Novel ibuprofen hydrogels self-assembled with biocompatible amino acids: mechanistic understanding and performance optimization

    by Xiaoqian Liu, Mingjun Li, Wuheng Yue, Zhimin Yue, Xinru Lu, Baimin Niu, Huizhen Sun, Jue Wang, Jiawei Han

    This study presents a practical formulation strategy by designing hydrogels of acidic drugs with basic amino acids to enhance their release and permeability for performance optimization of poorly soluble components.

  • Incorporation of molecular complexation into novel etodolac hydrogels: A strategy for dramatic enhancement of drug release

    by Xiaoqian Liu, Baimin Niu, Wuheng Yue, Zhimin Yue, Huizhen Sun, Mingjun Li, Xinru Lu, Jue Wang, Jiaxin Chen, Jiawei Han

  • Temperature-Dependent Crystallization Pathways of the Curcumin-Magnolol Coamorphous System: A Mechanistic Study Integrating Thermodynamics and Kinetics

    by Ke Zhang, Yu Chen, Fei Ding, Jiali Yu, Yutong Song, Jiawei Han, Yuanfeng Wei, Yuan Gao, Mi Tang, Jianjun Zhang, et al.

    Coamorphous drug systems have received increasing interest owing to their potential to improve the solubility, dissolution, and bioavailability of insoluble drugs. However, coamorphous systems exist in a high-energy state, making them prone to crystallization into stable forms. In this study, the curcumin-magnolol coamorphous (CUR-MAG CA) system was found to crystallize into different phases, with different crystallization kinetics, depending on temperature: (1) MAG crystal at 30–40 °C, (2) CUR-MAG cocrystal at 50–80 °C, and (3) CUR crystal at 90–100 °C. By integrating thermodynamic and kinetic analyses, we propose a mechanistic framework for the crystallization pathways of the CUR-MAG CA system. At lower temperatures (T < Tf (41.1 °C), Tf is the critical point where molecular mobility significantly increases, determined by dynamic mechanical analysis (DMA)), crystallization is associated with a high degree of undercooling and high viscosity, and the CUR-MAG CA system preferentially transforms into the kinetically favored phase. At moderate temperatures (Tf < T < Tm-MAG (101.4 °C)), molecular mobility becomes sufficient, enabling the system to preferentially transform into the thermodynamically stable phase. At higher temperatures (T > Tm-MAG), the thermodynamic driving force for MAG crystallization vanishes in the absence of supercooling, thereby favoring crystallization of CUR, which possesses the higher melting point (Tm-CUR = 181.9 °C). This study provides insight into the temperature-dependent crystallization behavior of coamorphous systems and may contribute to the development of more stable pharmaceutical formulations.

  • Mechanistic Insight into Self-Gelation Involved in Prescription Design for Optimization of Tablet Performance

    by Xiaoqian Liu, Weitao Fang, Ruijie Zhang, Wuheng Yue, Zhiwei Xiong, Baimin Niu, Huizhen Sun, Jiaxin Chen, Jue Wang, Jiawei Han

    Some drugs undergo gelation during the formulation development process, which not only poses significant challenges to the manufacturing process of solid dosage forms but also significantly restricts the drug dissolution and absorption. Could such gelation be utilized by designing the prescription to overcome the adverse effects and water solubility defect of drugs? Herein, this study attempted to design the self-gelation tablets of indomethacin (IND) by introducing small-molecule ligands and to explore the self-gelation mechanism. As a result, the designed tablets occurred to have spontaneous gelation with a typical 3D structure and viscoelasticity upon contact with a small amount of water, accompanied by amorphization transformation. Such a self-gelation behavior was significantly influenced by the composition ratios, storage temperatures, and medium pH values. In comparison to pure IND tablet, the designed IND-ligand tablets performed significantly increased apparent solubility (>200-fold) and intrinsic dissolution rate (>6000-fold) and maintained the long-term supersaturated dissolution with acid–base interactions, which was revealed by nucleation inhibition, fluorescence quenching, and phase solubility tests. Moreover, the self-gelled tablets significantly enhanced the membrane permeability of IND, demonstrating the potential for promoting oral absorption. Thus, this study revealed the self-gelation mechanism of the tablet combination and confirmed such prescription design involving self-gelation as an efficient solubilization strategy.

  • Open Access

    Incorporation of Molecular Complexation into Novel Etodolac Hydrogels: A Strategy for Dramatic Enhancement of Drug Release

    by Xiaoqian Liu, Baimin Niu, Wuheng Yue, Zhimin Yue, Huizhen Sun, Mingjun Li, Xinru Lu, Jue Wang, Jiaxin Chen, Jiawei Han

    Driven by advances in gel research, pharmaceutical small-molecule hydrogels are gaining significant attention as drug delivery systems. This study explored the viability of designing small-molecule hydrogels as a solubilization approach, using the poorly water-soluble etodolac (ETO) as a model compound. The novel ETO hydrogels were yielded by simple mixing of ETO with biocompatible small-molecule ligands in minimal deionized water. These hydrogels displayed characteristic three-dimensional network structures with pronounced viscoelastic properties. Through comprehensive characterization and molecular simulation analyses, it was demonstrated that hydrogel formation was dependent on three crucial factors: favorable miscibility between ETO and ligands, a dynamic equilibrium between dissolution and aggregation, as well as self-assembly processes fueled by intermolecular interactions in the aqueous phase. Remarkably, the solubility of ETO within these hydrogels exceeded that of pure ETO by over 16-fold. Furthermore, the novel ETO hydrogels demonstrated enhanced release kinetics and supersaturation maintenance capacity, achieving rapid peak concentrations followed by sustained supersaturated release owing to amorphization and molecular complexation. These beneficial characteristics arose from the inherent high-energy state of the hydrogels, as well as the complexation interaction between ETO and the ligand throughout the release process. Overall, this study validated the rational design of small-molecule hydrogel systems as an effective formulation approach to overcome the poor aqueous solubility of challenging ingredients.

  • Mechanistic Insight into Formation and Release Enhancement of Sulindac-Amino Acid Small-Molecule Hydrogels

    by Jiaxin Chen, Huizhen Sun, Wuheng Yue, Zhimin Yue, Baimin Niu, Mingjun Li, Xinru Lu, Jue Wang, Xiaoqian Liu, Jiawei Han

    As research on gels continues to advance, pharmaceutical small-molecule hydrogels have attracted growing interest in formulation development. This study addressed two key questions: whether small-molecule hydrogels could function as an effective solubilization strategy and how to design such hydrogel systems. Sulindac (SUL), a non-steroidal anti-inflammatory drug, is subject to significant limitations in clinical use owing to its low aqueous solubility. Herein, SUL-based small-molecule hydrogel systems were fabricated by simply mixing SUL with biocompatible amino acids in a small volume of deionized water. This study combined theoretical miscibility calculation, molecular dynamics simulation, and experimental verification (preparation, characterization, in vitro solubility and release assessments, etc.) to explore their formation and solubilization mechanisms. The formed SUL hydrogels with arginine (ARG) or lysine (LYS) exhibited characteristic three-dimensional network structures and excellent viscoelastic properties. Combined results from characterization analyses and molecular simulations revealed that hydrogel formation was promoted by three factors: favorable miscibility between SUL and ARG/LYS, a dissolution-aggregation equilibrium, and self-assembly driven by intermolecular interactions. Compared to pure SUL, the solubility of SUL in both hydrogels was enhanced more than 500-fold. Additionally, the novel SUL hydrogels demonstrated superior release kinetics and supersaturation capacity, characterized by rapid achievement of peak concentrations and sustained supersaturated release. These performances were attributed to the high-energy state of the hydrogels themselves and the complexation between SUL and ARG/LYS. This study presents a viable formulation approach for overcoming the poor water solubility of insoluble drugs through the design of small-molecule hydrogel formulations.

  • Mechanistic Insights and Dissolution Enhancement of Sulindac with Ionic Interaction through an In Situ Coamorphization Strategy

    by Weitao Fang, Huizhen Sun, Baimin Niu, Shuo Li, Huangliang Zhang, Jiaxin Chen, Jue Wang, Xiaoqian Liu, Jiawei Han

  • Open Access

    Insight into formation and release enhancement of etodolac small-molecule hydrogelsthroughamorphization and molecular complexation

    by Xiaoqian Liu, Baimin Niu, Zhimin Yue, Huizhen Sun, Mingjun Li, Xinru Lu, Zhiwei Xiong, Jue Wang, Jiawei Han, Wuheng Yue

    Driven by advances in gel research, limited pharmaceutical small-molecule hydrogels begun to attract attention. However, their potentials were not transformed into practical formulation development. Herein, this study used poorly water-soluble etodolac (ETO) as a model to explore the solubilization feasibility and effective design of such hydrogels. The novel ETO hydrogels were prepared by simply mixing ETO with biocompatible small-molecule ligands in minimal deionized water, exhibiting 3D network structures and pronounced viscoelasticity. Comprehensive characterization and molecular simulations revealed hydrogel formation relied on the favorable ETO-ligand miscibility, dissolution-aggregation equilibrium, and self-assembly driven by intermolecular interactions in aqueous environments. Remarkably, ETO solubility in these hydrogels was over 16-fold higher than pure ETO and they also showed enhanced release kinetics and supersaturation maintenance owing to amorphization and molecular complexation. In summary, this work establishes the design of small-molecule hydrogel systems as a feasible formulation strategy to address the water insolubility of challenging drugs.

  • Design of Coamorphous Systems for Flavonoid Components Coformed with Meglumine by Integrating Theory-Model-Experiment Techniques

    by Jiawei Han, Wen Sun, Jiaxin Chen, Zhimin Yue, Weitao Fang, Xiaoqian Liu, Jue Wang, Gaorong Wu

    Flavonoids represent an extensive group of phenolic substances in vegetables, fruits, grains, tea, flowers, etc., which show a variety of biological activities in various nutraceutical, cosmetic, and medicinal fields. Despite demonstrating multifunctional bioactive properties relevant to nutraceutical and pharmaceutical applications, their clinical utilization faces challenges due to their generally low water solubility. This study established a systematic methodology combining computational modeling and experimental validation for developing flavonoid-meglumine (MEG) coamorphous formulations. The initial screening identified 13 flavonoid compounds exhibiting favorable miscibility with MEG from 15 candidates through Hansen solubility parameter analysis. Subsequent molecular dynamics simulations revealed potential hydrogen bond formation in six selected flavonoids (BAI, HES, NAR, KAE, QUE, and ISO) with MEG. Then, six flavonoid coamorphous systems were successfully prepared via the melt-quenching method and characterized by PLM, PXRD, and differential scanning calorimetry. FTIR and radial distribution function analysis results collectively confirmed intermolecular hydrogen bond interactions within these binary systems. In vitro dissolution studies revealed significant solubility/dissolution enhancement in both pH 1.2 HCl and pH 6.8 phosphate buffers, maintaining long-term supersaturation for all six coamorphous formulations. Meanwhile, six flavonoid coamorphous systems had superior stability over individual flavonoid amorphous components, which were attributed to the stronger intermolecular interactions by higher binding energy calculation. These results indicated that the obtained flavonoid coamorphous systems performed a promising application potential in functional products. Importantly, this study presents a novel design framework integrating computational prediction, molecular modeling, and experimental validation for systematic screening of flavonoid coamorphous formulations.


  • A New Screening Strategy for Flavonoid Components to Obtain a Satisfactory Co-Amorphous System with Piperine

    by Jiawei Han, Wen Sun, Yongxu Yao, Shuo Li, Zhimin Yue, Weitao Fang, Xiaoqian Liu, Jue Wang, Jiaxin Chen

    Flavonoids are a large class of compounds with a variety of biological activities. Nevertheless, their therapeutic application remains limited due to the g